Skip to main content
Premium Trial:

Request an Annual Quote

Genetic Technologies Lab Gets Regulatory Approvals in US, Australia

NEW YORK — Genetic Technologies said on Tuesday that its lab has received regulatory approvals in Australia and the US that will enable the commercial launch of its GeneType risk-assessment test for certain cancers and other diseases in those markets.

The test is designed to analyze an individual's personal clinical, family, and genetic data to determine their likelihood of developing breast, colorectal, prostate, and ovarian cancers, as well as coronary artery disease and type 2 diabetes.

The Melbourne, Australia-based company said that its lab has recently received accreditation from Australia's National Association of Testing Authorities and CLIA certification from the US Centers for Medicare & Medicaid Services, clearing the way for a commercial release of the test for healthcare professionals in the two countries this week.

"There is a substantial market opportunity for this [test], and we are excited to leverage our expanded sales and marketing platform to bring this product to market," Genetic Technologies CEO Simon Morriss said in a statement. "This test will provide a proactive assessment test for patients and clinicians with the aim to improve patient outcomes in the long term."

In September, Genetic Technologies partnered with Washington University's Institute for Public Health on a study designed to expand the predictive capability of its GeneType for breast cancer in women of African descent.

The Scan

Nature Papers on Long Reads for Bacterial Genomes, Zebrafish Atlas, Hypothalamic Aging in Mammals

In Nature this week: near-finished microbial genomes without polishing, zebrafish functional annotation program, and more. 

Rise of BA.5

The New York Times reports that the Omicron subvariant BA.5 has become the dominant version of SARS-CoV-2 in the US.

UK Health Secretary Resigns

Sajid Javid, the UK health secretary, resigned along with Chancellor Rishi Sunak, saying they cannot work with Prime Minister Boris Johnson's government, CNN reports.

Clones From Freeze-Dried Cells

A team in Japan has cloned mice from freeze-dried skin cells, according to the Guardian.